Kolexia
Dupuis Olivier Oncologie radiothérapie
Dupuis Olivier
Oncologie radiothérapie
Gcs Medecine Nucleaire Sarthe_et Siege
Le Mans, France
71 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs du rectum Adénocarcinome Tumeurs du côlon Carcinomes Tumeurs de l'oesophage Tumeurs de la tête et du cou Tumeurs du poumon

Collaborateurs

Voir plus
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France
Lledo Gerard
Lledo Gerard
Centre Léon-Bérard, Lyon, France
Louvet Christophe
Louvet Christophe
Institut Mutualiste Montsouris, Paris, France
Denis Fabrice
Denis Fabrice
Gcs Medecine Nucleaire Sarthe_et Siege, Le Mans, France

Industries

Voir plus
Janssen
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
IDEA: A Phase III Randomized Trial Investigating the Duration of Adjuvant Therapy(3 Versus 6 Months) With the Modified FOLFOX 6 or XELOX Regimens for Patients With Stage III Colon Cancer
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   27 septembre 2023
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.
Journal of medical Internet research   15 février 2023
390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study.
2022 ASCO Annual Meeting I   02 juin 2022
Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology   14 octobre 2021
PERSPECTIVE: Tepotinib + cetuximab in patients (pts) with RAS/BRAF wild-type left-sided metastatic colorectal cancer (mCRC) and acquired resistance to anti-EGFR antibody therapy due to MET amplification (METamp).
2021 ASCO Annual Meeting I   28 mai 2021
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer: Randomized Phase III Trial Comparing in a Preoperative Schedule the Result of Two Concurrent Chemoradiation Schemes (45 Gy + Capecitabine vs 50 Gy + Capecitabine - Oxaliplatin) on the Rate of Sterilization of the Operative Specimen in Resectable Rectal Carcinomas T3-4 No-2 Mo
Essai Clinique (Unicancer)   15 février 2021
How a self-managed team can improve cohesion and communication during the patient's journey in a radiotherapy department: Experience of centre Jean-Bernard (Le Mans, France).
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   15 août 2020
REVEH: Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care
Essai Clinique (Weprom)   22 juin 2020
Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   13 mars 2020